AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2024
Jun 5, 2024
32559_dirs_2024-06-04_ff4b42bf-3624-4f6b-88a5-659bc411631c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2024-05-31
Reporting Person: Vignola Mark J. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-31 | Common Stock | P | 4791.00 | $4.44 | Acquired | 91940.00 | Direct |
Footnotes
F1: Includes the purchase of 4,791 shares under the Terns Employee Stock Purchase Plan on May 31, 2024.